We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+19.18%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$14.1B
AUM Growth
+$3.8B
Cap. Flow
+$2.09B
Cap. Flow %
14.81%
Top 10 Hldgs %
19.63%
Holding
2,124
New
675
Increased
443
Reduced
410
Closed
576

Top Sells

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$131M
2
MSFT icon
Microsoft
MSFT
+$129M
3
V icon
Visa
V
+$119M
4
BKNG icon
Booking.com
BKNG
+$86M
5
HUM icon
Humana
HUM
+$82.2M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 15.37%
3 Consumer Discretionary 10.44%
4 Industrials 8.59%
5 Financials 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
1001
Tesla
TSLA
$1.3T
$186K ﹤0.01%
+9,945
New +$200K
APTV icon
1002
Aptiv
APTV
$10.2B
$183K ﹤0.01%
2,300
-3,264
-59% -$251K
URI icon
1003
United Rentals
URI
$71.3B
$183K ﹤0.01%
+1,600
New +$198K
ACOR
1004
DELISTED
Acorda Therapeutics
ACOR
$183K ﹤0.01%
+115
New +$207K
DOC icon
1005
Healthpeak Properties
DOC
$14.5B
$182K ﹤0.01%
+5,800
New +$177K
FARO
1006
DELISTED
Faro Technologies
FARO
$180K ﹤0.01%
+4,094
New +$181K
FRPT icon
1007
Freshpet
FRPT
$3.29B
$180K ﹤0.01%
4,247
-3,919
-48% -$151K
MYRG icon
1008
MYR Group
MYRG
$5.19B
$180K ﹤0.01%
+5,205
New +$169K
PAGS icon
1009
PagSeguro Digital
PAGS
$2.55B
$180K ﹤0.01%
+6,029
New +$150K
ADNT icon
1010
Adient
ADNT
$1.46B
$179K ﹤0.01%
+13,793
New +$241K
SYRE icon
1011
Spyre Therapeutics
SYRE
$9.27B
$179K ﹤0.01%
+892
New +$186K
VRNS icon
1012
Varonis Systems
VRNS
$5.02B
$179K ﹤0.01%
9,015
-11,640
-56% -$221K
VRA icon
1013
Vera Bradley
VRA
$97.8M
$177K ﹤0.01%
+13,359
New +$137K
PRMW
1014
DELISTED
Primo Water Corporation
PRMW
$176K ﹤0.01%
12,046
-65,754
-85% -$988K
ARES icon
1015
Ares Management
ARES
$30.5B
$175K ﹤0.01%
+7,537
New +$165K
EFC
1016
Ellington Financial
EFC
$1.68B
$175K ﹤0.01%
+9,760
New +$164K
KALV
1017
DELISTED
KalVista Pharmaceuticals
KALV
$175K ﹤0.01%
+6,126
New +$133K
ESS icon
1018
Essex Property Trust
ESS
$18.1B
$174K ﹤0.01%
600
-24,071
-98% -$6.57M
WLY icon
1019
John Wiley & Sons Class A
WLY
$2.63B
$174K ﹤0.01%
+3,931
New +$193K
EXR icon
1020
Extra Space Storage
EXR
$30.7B
$173K ﹤0.01%
+1,700
New +$163K
JEF icon
1021
Jefferies Financial Group
JEF
$12.8B
$173K ﹤0.01%
10,280
-40,318
-80% -$712K
PDS
1022
Precision Drilling
PDS
$1.02B
$173K ﹤0.01%
+3,613
New +$163K
CHD icon
1023
Church & Dwight Co
CHD
$24.5B
$171K ﹤0.01%
2,400
-14,359
-86% -$945K
JNPR
1024
DELISTED
Juniper Networks
JNPR
$169K ﹤0.01%
6,401
-349,149
-98% -$9.4M
CHA
1025
DELISTED
China Telecom Corporation, LTD
CHA
$169K ﹤0.01%
+3,011
New +$163K

Similar funds

Marshall Wace North America's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace North America held 2,124 positions worth $14.1B, up 37% from $10.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America deployed $2.09B of net new capital in Q1 2019, opening 675 new positions and adding to 443 existing holdings. Its largest new stake was bluebird bio: 36,744 shares worth $74.9M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Comcast, an estimated $131M trimmed.

  • Marshall Wace North America's largest Q1 2019 buy was bluebird bio: 36,744 shares worth $74.9M.
  • Marshall Wace North America added most to Fidelity National Information Services in Q1 2019, an estimated $188M increase.
  • Marshall Wace North America's biggest Q1 2019 reduction was Comcast, cutting an estimated $131M.
  • Marshall Wace North America fully exited Cboe Global Markets in Q1 2019, selling an estimated $67.7M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $14.1B portfolio in Q1 2019.
  • Marshall Wace North America opened 675 new positions and closed 576 in Q1 2019.
  • Marshall Wace North America's portfolio value rose 37% quarter-over-quarter to $14.1B.

Based on Marshall Wace North America's 13F filing for Q1 2019, filed 14 May 2019.